Dr. Matthew Christopher Brennan, MD

  • Lancaster, PA
  • Hematologist and oncologist
NPI1639312739PAC ID0143532143
Medicare services, 2024
1,052
Medicare patients, 2024
430
Part D claims, 2024
1,862
Publications
3
Hospital affiliations
3
Practice address
2102 Harrisburg Pike, Lancaster, PA 17601
Practice phone
Call (717) 544-9400
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Penn Medicine Lancaster General Health Physicians Hematology &Oncology

Lancaster, Pennsylvania

See all 6 affiliations

Find Dr. Brennan's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Matthew Christopher Brennan is a hematologist and oncologist in Lancaster, Pennsylvania

Dr. Brennan practices at Penn Medicine Lancaster General Health Physicians Hematology &Oncology in Lancaster, Pennsylvania.

Dr. Brennan's NPI, 1639312739, was assigned on April 20, 2009. Dr. Brennan graduated from Pennsylvania State University College of Medicine in 2009. Dr. Brennan holds Pennsylvania license MD454667.

NPI and contact details
Medicare PAC ID
0143532143
NPI enumeration date
April 20, 2009
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(717) 544-9400
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
43
Medical school graduation
2009

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Matthew Christopher Brennan practices at Penn Medicine Lancaster General Health Physicians Hematology &Oncology in Lancaster, Pennsylvania

Dr. Brennan's primary practice is Penn Medicine Lancaster General Health Physicians Hematology &Oncology, at 2102 Harrisburg Pike, Lancaster, PA 17601 in Lancaster County. The practice phone is (717) 544-9400.

  • Penn Medicine Lancaster General Health Physicians Hematology &Oncology
    2102 Harrisburg Pike, Lancaster, PA 17601 · Lancaster CountyPhone(717) 544-9400

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Matthew Christopher Brennan is affiliated with 5 sites of care and 1 medical group

Dr. Brennan's primary practice is Penn Medicine Lancaster General Health Physicians Hematology &Oncology in Lancaster, Pennsylvania. Dr. Brennan is also affiliated with Lancaster General Hospital. The medical group on file is Penn Medicine Lancaster General Health Physicians, Behavioral Health. Dmand AI also links Dr. Brennan to 2 more hospitals and 1 group practice or clinic, each named with a free account.

See all 6 affiliations for Dr. Brennan

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Matthew Christopher Brennan's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brennan practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Penn Medicine Lancaster General Health Physicians Hematology &OncologyAvailable with a free account
+4 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Brennan practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Matthew Christopher Brennan is one of 645 hematologists and oncologists in Pennsylvania

Hematology and oncology is Dr. Brennan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Brennan is licensed in Pennsylvania.

Specialties and state licenses

  • Hematology and oncology, PennsylvaniaPrimaryLicense MD454667 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Brennan

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Matthew Christopher Brennan billed Medicare for 1,052 services in 2024

CMS data shows 1,052 Medicare services from Dr. Brennan across 13 procedure codes in 2024, for 430 Medicare patients. Medicare paid $92,703 for them.

Medicare services, 20241,052
Medicare patients430
Paid by Medicare$92,703
Procedure codes13

Dr. Brennan's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1,0502024: 9638%
Other services
2023: 02024: 89

Where Dr. Brennan's Medicare services took place, 2024

  • In an office92788%
  • In a facility12512%

Dr. Brennan compared with the Pennsylvania median for hematologists and oncologists, 2024

  • Dr. Brennan
  • Pennsylvania median
Medicare services
1,052vs 65461% above
Medicare patients
430vs 22789% above
Part D claims
1,549vs 3933.9 times

Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.

Dr. Brennan's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Brennan

Need commercial claims for Dr. Brennan?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Brennan and other hematologists and oncologists in Pennsylvania.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Matthew Christopher Brennan treated 430 Medicare patients in 2024, average age 75

CMS counts 430 Medicare patients who saw Dr. Brennan in 2024. The largest group is 65 to 74, with 190 patients. 74% of them have high blood pressure, and 74% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brennan's median patient age at 73, with 42% women.

Medicare patients, 2024430
Average age75
Average risk score2.26
Also on Medicaid5%

Dr. Brennan's Medicare patients by age, 2024

Dr. Brennan's Medicare patients by sex, 2024

  • Women15436%
  • Men27664%

Chronic conditions among Dr. Brennan's Medicare patients, 2024

  1. High blood pressure74%
  2. High cholesterol74%
  3. Cancer54%
  4. Arthritis47%
  5. Chronic kidney disease38%
  6. Diabetes30%
  7. Ischemic heart disease30%
  8. Heart failure26%

Share of Medicare patients with each condition. A patient can have several.

Dr. Brennan's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women42%
  • Men57%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Matthew Christopher Brennan wrote 1,862 Medicare Part D claims in 2024

In 2024, Dr. Brennan wrote 1,862 Medicare Part D claims for 282 patients. 71% of them were for generic drugs. CMS names the drug for 1,549 of them, across 42 drugs with 11 or more claims each, at $3,985,638 in total drug cost. In 2023, CMS named 1,404 claims across 37 drugs.

Part D claims, 20241,862
Drugs named by CMS42
Total drug cost$4M
Part D patients282

Dr. Brennan's Part D claims by kind of drug, 2024

  • Generic1,331 claims71%
  • Brand-name531 claims29%

Dr. Brennan's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Brennan's Part D claims, 2024

  • Opioids7%123 of 1,862 claims
  • Antibiotics2%42 of 1,862 claims
  • Antipsychotics, patients 65 and over3%58 of 1,862 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,4042024: 1,54910%

Drugs named by CMS: 42 in 2024, 37 in 2023.

See all prescribing by Dr. Brennan

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Matthew Christopher Brennan offers telehealth to Medicare patients

Dr. Brennan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brennan as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Brennan by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Matthew Christopher Brennan has 3 publications on record

Dmand AI links 3 papers to Dr. Brennan in 2013. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Brennan has published most often in Cancer Biol Ther. Dr. Brennan's most frequent co-authors are Timothy Judd Brown, MD, Thomas Dykes, MD and Michael J. Glantz, MD.

Papers3

Topics Dr. Brennan writes about most

  • Antineoplastic Combined Chemotherapy Protocols

Dr. Brennan's most frequent co-authors

Recent publications by Dr. Brennan

See all 3 publications and co-authors

See who Dr. Brennan researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Brennan works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Matthew Christopher Brennan received $291 in industry payments from 2017 to 2023

CMS Open Payments shows 6 general payments to Dr. Brennan from 6 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 96% of the total. Alexion Pharmaceuticals, Inc. paid the most, $121.

General payments to Dr. Brennan by program year, 2017 to 2023

General payments to Dr. Brennan by kind, 2017 to 2023

$291in total
  • Food and beverage$28096%
  • Education$124%

Companies that paid Dr. Brennan the most, 2017 to 2023

Share is of all general payments to this clinician.

See all payments to Dr. Brennan

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Matthew Christopher Brennan graduated from Pennsylvania State University College of Medicine

Dr. Brennan graduated from Pennsylvania State University College of Medicine in 2009.

  1. Medical schoolPennsylvania State University College of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Matthew Christopher Brennan's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Matthew Christopher Brennan

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Matthew Christopher Brennan's NPI number?

Dr. Matthew Christopher Brennan's NPI number is 1639312739. It was assigned on April 20, 2009, and it is active in the NPI Registry.

What kind of doctor is Dr. Matthew Christopher Brennan?

Dr. Matthew Christopher Brennan is a hematologist and oncologist in Lancaster, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Matthew Christopher Brennan practice?

Dr. Brennan practices at 2102 Harrisburg Pike, Lancaster, PA 17601. Dr. Brennan's primary practice is Penn Medicine Lancaster General Health Physicians Hematology &Oncology in Lancaster, Pennsylvania. Dmand AI also links Dr. Brennan to 2 hospitals and 1 group practice or clinic.

What is Dr. Matthew Christopher Brennan's office phone number?

The practice phone on file for Dr. Brennan is (717) 544-9400.

What is Dr. Matthew Christopher Brennan's medical license number?

Dr. Brennan holds Pennsylvania license MD454667.

Which hospitals is Dr. Matthew Christopher Brennan affiliated with?

Dr. Brennan is affiliated with Lancaster General Hospital. Dmand AI links Dr. Brennan to 2 more hospitals.

What medical group is Dr. Matthew Christopher Brennan part of?

Dr. Brennan is linked to Penn Medicine Lancaster General Health Physicians, Behavioral Health.

Does Dr. Matthew Christopher Brennan accept Medicare?

Yes. CMS data shows Dr. Brennan billed Medicare for 1,052 services in 2024, and Dr. Brennan accepts Medicare assignment.

Does Dr. Matthew Christopher Brennan offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Brennan as offering telehealth services.

How many Medicare patients does Dr. Matthew Christopher Brennan see?

CMS counts 430 Medicare patients who saw Dr. Brennan in 2024, with an average age of 75.

Show 7 more questionsShow fewer questions

What services does Dr. Matthew Christopher Brennan bill to Medicare?

In 2024, Dr. Brennan's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and office visit, established patient (99213).

Where did Dr. Matthew Christopher Brennan go to medical school?

Dr. Brennan graduated from Pennsylvania State University College of Medicine in 2009.

What drugs does Dr. Matthew Christopher Brennan prescribe most?

In 2024 Medicare Part D data, Dr. Brennan's most prescribed drugs by claims were Eliquis, Prednisone and Ondansetron HCl.

Has Dr. Matthew Christopher Brennan received payments from drug or device companies?

CMS Open Payments shows $291 in general payments to Dr. Brennan from 6 companies from 2017 to 2023. The largest total came from Alexion Pharmaceuticals, Inc.

How long has Dr. Matthew Christopher Brennan been practicing?

Dr. Brennan graduated from medical school in 2009, 17 years ago.

Does Dr. Matthew Christopher Brennan do research?

Dmand AI links 3 publications to Dr. Brennan.

Who does Dr. Matthew Christopher Brennan publish with?

Dr. Brennan's most frequent co-authors are Timothy Judd Brown, MD (1 shared paper), Thomas Dykes, MD (1 shared paper) and Michael J. Glantz, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in Pennsylvania by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)